메뉴 건너뛰기




Volumn 8, Issue 6, 1997, Pages 323-328

Varicella zoster virus infections in Canadian children in the prevaccine era: A hospital-based study

Author keywords

Childhood; Complications; Varicella zoster infections

Indexed keywords

ACICLOVIR; VARICELLA ZOSTER VACCINE;

EID: 0031458896     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/742365     Document Type: Article
Times cited : (10)

References (24)
  • 2
    • 0026780463 scopus 로고
    • Complications of varicella requiring hospitalization in previously healthy children
    • Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992;11:441-5.
    • (1992) Pediatr Infect Dis J , vol.11 , pp. 441-445
    • Jackson, M.A.1    Burry, V.F.2    Olson, L.C.3
  • 5
    • 0001074519 scopus 로고
    • Complications of varicella I: Their occurrence among 2534 patients
    • Bullowa JGM, Wishik SM. Complications of varicella I: their occurrence among 2534 patients. Am J Dis Child 1935;49:923-6.
    • (1935) Am J Dis Child , vol.49 , pp. 923-926
    • Bullowa, J.G.M.1    Wishik, S.M.2
  • 6
    • 0030028895 scopus 로고    scopus 로고
    • Risk factors for invasive group a streptococcal infections in children with varicella: A case-control study
    • Peterson CL, Vugia DJ, Meyers HB, et al. Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J 1996;15:151-6.
    • (1996) Pediatr Infect Dis J , vol.15 , pp. 151-156
    • Peterson, C.L.1    Vugia, D.J.2    Meyers, H.B.3
  • 7
    • 0027957687 scopus 로고
    • Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults
    • Davies HD, Matlow A, Scriver SR, et al. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 1994;13:49-56.
    • (1994) Pediatr Infect Dis J , vol.13 , pp. 49-56
    • Davies, H.D.1    Matlow, A.2    Scriver, S.R.3
  • 8
    • 0029778918 scopus 로고    scopus 로고
    • A prospective, population-based study of invasive group A streptococcal infections, including streptococcal toxic shock syndrome and the risk of disease transmission
    • Davies HD, McGeer A, Schwartz B, et al. A prospective, population-based study of invasive group A streptococcal infections, including streptococcal toxic shock syndrome and the risk of disease transmission. N Engl J Med 1996;335:547-54.
    • (1996) N Engl J Med , vol.335 , pp. 547-554
    • Davies, H.D.1    McGeer, A.2    Schwartz, B.3
  • 9
    • 0019479060 scopus 로고
    • Age-specific risks of varicella complications
    • Preblud SR. Age-specific risks of varicella complications. Pediatrics 1981;68:14-7.
    • (1981) Pediatrics , vol.68 , pp. 14-17
    • Preblud, S.R.1
  • 10
    • 0025897127 scopus 로고
    • Varicella-zoster infection in adults with cystic fibrosis: Role of acyclovir
    • Ong EL, Mulvenna P, Webb KA. Varicella-zoster infection in adults with cystic fibrosis: Role of acyclovir. Scand J Infect Dis 1991;23:283-5.
    • (1991) Scand J Infect Dis , vol.23 , pp. 283-285
    • Ong, E.L.1    Mulvenna, P.2    Webb, K.A.3
  • 12
    • 2442723064 scopus 로고
    • Chickenpox: Prevention and treatment
    • Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Chickenpox: Prevention and treatment. Can J Paediatr 1994;1:88-93.
    • (1994) Can J Paediatr , vol.1 , pp. 88-93
  • 13
    • 0027473704 scopus 로고
    • Oral acyclovir to prevent dissemination of varicella in immunocompromised children
    • Meszner Z, Nyerges G, Bell AR. Oral acyclovir to prevent dissemination of varicella in immunocompromised children. J Infect 1993;26:9-15.
    • (1993) J Infect , vol.26 , pp. 9-15
    • Meszner, Z.1    Nyerges, G.2    Bell, A.R.3
  • 14
    • 0021682032 scopus 로고
    • Varicella: Clinical manifestations, epidemiology and health impact in children
    • Preblud SR, Orenstein WA, Bart KJ. Varicella: Clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis 1984;3:505-9.
    • (1984) Pediatr Infect Dis , vol.3 , pp. 505-509
    • Preblud, S.R.1    Orenstein, W.A.2    Bart, K.J.3
  • 15
    • 0019946436 scopus 로고
    • Acyclovir therapy of chickenpox in immunosuppressed children - A collaborative study
    • Prober CG, Kirk LE, Keeney DO. Acyclovir therapy of chickenpox in immunosuppressed children - A collaborative study. J Pediatr 1982;101:622.
    • (1982) J Pediatr , vol.101 , pp. 622
    • Prober, C.G.1    Kirk, L.E.2    Keeney, D.O.3
  • 16
    • 84942475544 scopus 로고
    • Cost-effectiveness of a routine varicella vaccination program for US children
    • Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994;271:375-81.
    • (1994) JAMA , vol.271 , pp. 375-381
    • Lieu, T.A.1    Cochi, S.L.2    Black, S.B.3
  • 17
    • 0022510381 scopus 로고
    • Varicella: Complications and costs
    • Preblud SR. Varicella: Complications and costs. Pediatrics 1986;78(Suppl):728-35.
    • (1986) Pediatrics , vol.78 , Issue.SUPPL. , pp. 728-735
    • Preblud, S.R.1
  • 18
    • 0025762781 scopus 로고
    • Varicella vaccine (VARIVAX) in healthy children and adolescents; results from the clinical trials, 1987 to 1989
    • White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents; results from the clinical trials, 1987 to 1989. Pediatrics 1991;87:604-10.
    • (1991) Pediatrics , vol.87 , pp. 604-610
    • White, C.J.1    Kuter, B.J.2    Hildebrand, C.S.3
  • 19
    • 0022149678 scopus 로고
    • Live Oka/Merck varicella vaccine healthy children
    • Weibel RE, Kuter BJ, Neff BJ, et al. Live Oka/Merck varicella vaccine healthy children. JAMA 1985;254:2435-9.
    • (1985) JAMA , vol.254 , pp. 2435-2439
    • Weibel, R.E.1    Kuter, B.J.2    Neff, B.J.3
  • 20
    • 0001182759 scopus 로고
    • Live attenuated varicella vaccine: Current status and future uses
    • Gershon AA, LaRussa P, Steinberg S. Live attenuated varicella vaccine: Current status and future uses. Semin Pediatr Infect Dis 1991;2:171-8.
    • (1991) Semin Pediatr Infect Dis , vol.2 , pp. 171-178
    • Gershon, A.A.1    LaRussa, P.2    Steinberg, S.3
  • 21
    • 0027328759 scopus 로고
    • An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients
    • Kitai IC, King S, Gafni A. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clin Infect Dis 1993;17:441-7.
    • (1993) Clin Infect Dis , vol.17 , pp. 441-447
    • Kitai, I.C.1    King, S.2    Gafni, A.3
  • 22
    • 0026411149 scopus 로고
    • The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia
    • Hardy IB, Gershon A, Steinberg SP, LaRussa P, Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med 1991;325:1545-50.
    • (1991) N Engl J Med , vol.325 , pp. 1545-1550
    • Hardy, I.B.1    Gershon, A.2    Steinberg, S.P.3    LaRussa, P.4
  • 23
    • 0028229451 scopus 로고
    • Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States
    • Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 1994;140:81-104.
    • (1994) Am J Epidemiol , vol.140 , pp. 81-104
    • Halloran, M.E.1    Cochi, S.L.2    Lieu, T.A.3    Wharton, M.4    Fehrs, L.5
  • 24
    • 0027530782 scopus 로고
    • The use of oral acyclovir in otherwise healthy children with varicella
    • Committee on Infectious Diseases, American Academy of Pediatrics. The use of oral acyclovir in otherwise healthy children with varicella. Pediatrics 1993;91:674-6.
    • (1993) Pediatrics , vol.91 , pp. 674-676


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.